87 related articles for article (PubMed ID: 9832951)
21. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
22. Effects of chronic nitric oxide activation or inhibition on early hepatic fibrosis in rats with bile duct ligation.
Mayoral P; Criado M; Hidalgo F; Flores O; Arévalo MA; Eleno N; Sánchez-Rodríguez A; López-Novoa JM; Esteller A
Clin Sci (Lond); 1999 Mar; 96(3):297-305. PubMed ID: 10029566
[TBL] [Abstract][Full Text] [Related]
23. The effects of simultaneous administration of alpha(2) -adrenergic agents with L-NAME or L-arginine on the development and expression of morphine dependence in mice.
Zarrindast MR; Homayoun H; Khavandgar S; Fayaz-Dastgerdi M; Fayaz-Dastgerdi M
Behav Pharmacol; 2002 Mar; 13(2):117-25. PubMed ID: 11981224
[TBL] [Abstract][Full Text] [Related]
24. Dynorphin-mediated antinociceptive effects of L-arginine and SIN-1 (an NO donor) in mice.
Chung E; Burke B; Bieber AJ; Doss JC; Ohgami Y; Quock RM
Brain Res Bull; 2006 Jul; 70(3):245-50. PubMed ID: 16861110
[TBL] [Abstract][Full Text] [Related]
25. Effect of mu and kappa opioids on injury-induced microglial accumulation in leech CNS: involvement of the nitric oxide pathway.
Yahyavi-Firouz-Abadi N; Tahsili-Fahadan P; Ostad SN
Neuroscience; 2007 Feb; 144(3):1075-86. PubMed ID: 17169497
[TBL] [Abstract][Full Text] [Related]
26. The effect of nitric oxide on fentanyl and haloperidol-induced catalepsy in mice.
Erkent U; Iskit AB; Onur R; Ilhan M
Eur J Anaesthesiol; 2006 Jul; 23(7):580-5. PubMed ID: 16507184
[TBL] [Abstract][Full Text] [Related]
27. Effects of nitric oxide synthase inhibitors in attenuating nicotine withdrawal in rats.
Jain R; Mukherjee K; Mohan D
Pharmacol Biochem Behav; 2008 Feb; 88(4):473-80. PubMed ID: 18031800
[TBL] [Abstract][Full Text] [Related]
28. Evidence for a role of nitric oxide of the central nervous system in morphine abstinence syndrome.
Bhargava HN; Thorat SN
Pharmacology; 1996 Feb; 52(2):86-91. PubMed ID: 8851629
[TBL] [Abstract][Full Text] [Related]
29. Comparison of simultaneous administration of lithium with L-NAME or L-arginine on morphine withdrawal syndrome in mice.
Dehpour AR; Sadr SS; Nouroddini M; Shadan F; Nourozi A; Farahani M; Sahebgharani M
Hum Psychopharmacol; 2000 Mar; 15(2):87-93. PubMed ID: 12404337
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone-precipitated withdrawal syndrome in morphine-dependent mice.
Cappendijk SL; de Vries R; Dzoljic MR
Neurosci Lett; 1993 Nov; 162(1-2):97-100. PubMed ID: 7510058
[TBL] [Abstract][Full Text] [Related]
31. Possible involvement of nitric oxide in morphine-induced miosis and reduction of intraocular pressure in rabbits.
Bonfiglio V; Bucolo C; Camillieri G; Drago F
Eur J Pharmacol; 2006 Mar; 534(1-3):227-32. PubMed ID: 16516192
[TBL] [Abstract][Full Text] [Related]
32. Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tramadol in the rat forced swimming test.
Jesse CR; Bortolatto CF; Savegnago L; Rocha JB; Nogueira CW
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1838-43. PubMed ID: 18773934
[TBL] [Abstract][Full Text] [Related]
33. Chronic administration of aminoguanidine reduces vascular nitric oxide production and attenuates liver damage in bile duct-ligated rats.
Wei CL; Hon WM; Lee KH; Khoo HE
Liver Int; 2005 Jun; 25(3):647-56. PubMed ID: 15910502
[TBL] [Abstract][Full Text] [Related]
34. delta-Opioid receptor agonist SNC80 elicits peripheral antinociception via delta(1) and delta(2) receptors and activation of the l-arginine/nitric oxide/cyclic GMP pathway.
Pacheco DF; Reis GM; Francischi JN; Castro MS; Perez AC; Duarte ID
Life Sci; 2005 Nov; 78(1):54-60. PubMed ID: 16135369
[TBL] [Abstract][Full Text] [Related]
35. The antinociceptive activity of Muntingia calabura aqueous extract and the involvement of L-arginine/nitric oxide/cyclic guanosine monophosphate pathway in its observed activity in mice.
Zakaria ZA; Sulaiman MR; Jais AM; Somchit MN; Jayaraman KV; Balakhrisnan G; Abdullah FC
Fundam Clin Pharmacol; 2006 Aug; 20(4):365-72. PubMed ID: 16867020
[TBL] [Abstract][Full Text] [Related]
36. Peripheral involvement of the nitric oxide-cGMP pathway in the indomethacin-induced antinociception in rat.
Ventura-Martínez R; Déciga-Campos M; Díaz-Reval MI; González-Trujano ME; López-Muñoz FJ
Eur J Pharmacol; 2004 Oct; 503(1-3):43-8. PubMed ID: 15496294
[TBL] [Abstract][Full Text] [Related]
37. The effect of cyclosporin A on morphine tolerance and dependence: involvement of L-arginine/nitric oxide pathway.
Homayoun H; Khavandgar S; Namiranian K; Dehpour AR
Eur J Pharmacol; 2002 Sep; 452(1):67-75. PubMed ID: 12323386
[TBL] [Abstract][Full Text] [Related]
38. Seizure susceptibility alteration following reversible cholestasis in mice: Modulation by opioids and nitric oxide.
Gholipour T; Riazi K; Noorian AR; Jannati A; Honar H; Doratotaj B; Nik HH; Shariftabrizi A; Dehpour AR
Eur J Pharmacol; 2008 Feb; 580(3):322-8. PubMed ID: 18164287
[TBL] [Abstract][Full Text] [Related]
39. Involvement of endogenous opioid peptides and nitric oxide in the blunted chronotropic and inotropic responses to beta-adrenergic stimulation in cirrhotic rats.
Ebrahimi F; Tavakoli S; Hajrasouliha AR; Sadeghipour H; Dehghani M; Ahmadi SH; Dehpour AR
Fundam Clin Pharmacol; 2006 Oct; 20(5):461-71. PubMed ID: 16968416
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of nitric-oxide synthase enhances antigen-induced contractions and increases release of cysteinyl-leukotrienes in guinea pig lung parenchyma: nitric oxide as a protective factor.
Larsson AK; Bäck M; Hjoberg J; Dahlén SE
J Pharmacol Exp Ther; 2005 Oct; 315(1):458-65. PubMed ID: 16024733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
